Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma

Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma

<p>Abstract</p> <p>Background</p> <p>Recently, maintaining higher relative dose intensity (RDI) of chemotherapeutic drugs has become a widespread practice in an attempt to achieve better outcomes in the treatment of aggressive lymphoma. The addition of rituximab to chem...

Full description

Bibliographic Details
Main Authors: Koh Ki-Ryang, Ohsawa Masahiko, Takeoka Yasunobu, Nakane Takahiko, Koh Hideo, Inoue Eri, Aimoto Mizuki, Sakamoto Erina, Kanashima Hiroshi, Aimoto Ran, Nakamae Hirohisa, Terada Yoshiki, Yamane Takahisa, Nakao Yoshitaka, Ohta Kensuke, Mugitani Atsuko, Teshima Hirofumi, Hino Masayuki
Format: Article
Language:English
Published: BMC 2009-08-01
Series:Journal of Experimental & Clinical Cancer Research
Online Access:http://www.jeccr.com/content/28/1/116

Internet

http://www.jeccr.com/content/28/1/116

Similar Items